Home
About
Contact
DISCLAIMER: This site is for informational purposes only. While we make every effort to keep it up to date, there is no guarantee that information is complete, accurate, comprehensive, or the same for all KP regions. The information on this site should not be interpreted or used as a substitute for professional medical care. Please consult your care provider for any personal health questions or before participating in clinical trials.
Search Results
Tip
Select Recruitment Status
Active, not yet recruiting
Active, currently enrolling
Active, enrolling only by invitation
Enrollment complete
Study completed
Enrollment on hold
Study terminated early
Select Study Type
INTERVENTIONAL
OBSERVATIONAL
Select Clinical Trial Type
Phase I
Phase II
Phase IIA
Phase IIB
Phase III
Phase IV
n/a
Select Clinical Area
Adolescent Medicine
Addiction Medicine
Allergy and Immunology
Anesthesiology
Cardiology
Complimentary and Alternative Med
Dermatology
Emergency Medicine
Endocrinology, Diabetes and Metabolism
Epidemiology
Family Medicine
Genetics
Geriatric Medicine
Gastroenterology
Hematology
Infectious Diseases
Internal Medicine
Nephrology
Lifestyle Medicine
Neurology/Neurological Disorders
Nuclear Medicine
Nursing
Obstetrics and Gynecology
Occupational Medicine
Oncology (Adult)
Oncology (Pediatrics)
Ophthalmology
Other
Otolaryngology/ENT
Pediatrics
Physical Medicine and Rehabilitation
Podiatric Medicine
Preventative Medicine
Psychiatry
Pulmonary Disease
Radiology
Rheumatology
Sports Medicine
Surgery (Colon and Rectal)
Surgery (General)
Surgery (Hand)
Surgery (Neurological)
Surgery (Orthopedic)
Surgery (Plastic)
Surgery (Thoracic)
Surgery (Urology)
Surgery (Vascular)
Urology
Select Regions
California - Northern
California - Southern
Colorado
Georgia
Hawaii
Mid-Atlantic
Northwest
Washington
Select Facility 1
Select Facility 2
Select Facility 3
Male
Female
Child (Birth - 17 yrs)
Adult (18 - 65 yrs)
Senior (66 and above)
Saved Studies
You currently don’t have any saved studies. To save a study, select the bookmark icon on the result listing.
Active, currently enrolling
Who can join
Connect for Cancer Prevention Study: A Prospective Cohort Study Within Integrated Healthcare Systems in the US
Keywords:
Risk Factors; Medical Conditions; Pathology; Blood; Urine; Natural History
Study Type:
Prospective Cohort Study with Direct Patient Contact |
Region:
Georgia
Active, currently enrolling
Who can join
EXActDNA-003 / NSABP B-64: Breast Cancer Clinical Validation Study to Predict Recurrence of High-Risk Early Breast Cancer Treated With Neoadjuvant Therapy Using a Bespoke Circulating Tumor DNA Assay to Detect Molecular Residual Disease
Keywords:
Oncology (Adult);Breast Cancer; ctDNA; Neoplasms by Site; Neoplasms; Breast…
Study Type:
OBSERVATIONAL |
Region:
California - Northern
Active, currently enrolling
Who can join
OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy With Checkpoint Inhibitor Therapy
Keywords:
Oncology (Adult);Obstetrics and Gynecology;
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Active, currently enrolling
Who can join
Case-Control Study II of Genomic Markers in Menstrual Blood for Diagnosis of Uterine Disorders
Keywords:
Obstetrics and Gynecology;Endometriosis; Uterine Disorders
Study Type:
OBSERVATIONAL |
Region:
Colorado
Enrollment complete
Who can join
Pragmatica-Lung: A Prospective Randomized Study of Ramucirumab (LY3009806; NSC 749128) Plus Pembrolizumab (MK-3475; NSC 776864) Versus Standard of Care for Participants Previously Treated With Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer
Keywords:
Oncology (Adult);Surgery (Thoracic);
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Active, not yet recruiting
Who can join
Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO)
Keywords:
Carcinoma; Lung Neoplasms; Carcinoma; Non-Small-Cell Lung; Carcinoma; Squamous…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Enrollment complete
Who can join
A RANDOMIZED PHASE III STUDY OF BENDAMUSTINE PLUS RITUXIMAB VERSUS IBRUTINIB PLUS RITUXIMAB VERSUS IBRUTINIB ALONE IN UNTREATED OLDER PATIENTS (= 65 YEARS OF AGE) WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Keywords:
Oncology (Adult);Hematology;
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Enrollment complete
Who can join
A Phase 2 Randomized Study of Irinotecan/Temozolomide/Dinutuximab With or Without Eflornithine (DFMO) in Children With Relapsed, Refractory or Progressive Neuroblastoma
Keywords:
Neuroblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Neuroectodermal…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Enrollment complete
Who can join
A Phase 3 Open-Label, Randomized, Controlled, Global Study of Telisotuzumab Vedotin (ABBV-399) Versus Docetaxel in Subjects with Previously Treated c-Met Overexpressing, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer
Keywords:
Oncology (Adult);
Study Type:
INTERVENTIONAL |
Region:
Hawaii
Active, currently enrolling
Who can join
A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy
Keywords:
Endometrial Neoplasms; Uterine Neoplasms; Genital Neoplasms; Female; Urogenital…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
1
2
3
4
5
6
7
8
9
10
...